0001209191-21-054430.txt : 20210902
0001209191-21-054430.hdr.sgml : 20210902
20210902161658
ACCESSION NUMBER: 0001209191-21-054430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duke William E.
CENTRAL INDEX KEY: 0001636135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38822
FILM NUMBER: 211233443
MAIL ADDRESS:
STREET 1: C/O VALERITAS, INC., 750 ROUTE 202 SOUTH
STREET 2: SUITE 600
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kaleido Biosciences, Inc.
CENTRAL INDEX KEY: 0001751299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 617-674-9000
MAIL ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-01
0
0001751299
Kaleido Biosciences, Inc.
KLDO
0001636135
Duke William E.
C/O KALEIDO BIOSCIENCES,INC
65 HAYDEN AVE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
6.29
2021-09-01
4
A
0
60000
0.00
A
2031-08-31
Common Stock
60000
60000
D
25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
/s/ William Duke, Jr.
2021-09-02